Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'myeloid' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 9096 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Van Limbergen, H; Poppe, B; Michaux, L; Herens, C; Brown, J; Noens, L; Berneman, Z; De Bock, R; De Paepe, A; Speleman, F
      Identification of cytogenetic subclasses and recurring chromosomal aberrations in AML and MDS with complex karyotypes using M-FISH

      GENES CHROMOSOMES & CANCER
    2. Maserati, E; Aprili, F; Vinante, F; Locatelli, F; Amendola, G; Zatterale, A; Milone, G; Minelli, A; Bernardi, F; Lo Curto, F; Pasquali, F
      Trisomy 8 in myelodysplasia and acute leukemia is constitutional in 15-20%of cases

      GENES CHROMOSOMES & CANCER
    3. Foss, B; Ulvestad, E; Hervig, T; Bruserud, O
      Effects of cytarabine and various anthracyclins on platelet activation: Characterization of in vitro effects and their possible clinical relevance inacute myelogenous leukemia

      INTERNATIONAL JOURNAL OF CANCER
    4. Ngu, IWY; Sinclair, EC; Greenaway, S; Greenberg, ML
      Unusual presentation of granulocytic sarcoma in the breast: A case report and review of the literature

      DIAGNOSTIC CYTOPATHOLOGY
    5. Bruserud, O
      Effects of azoles on human acute myelogenous leukemia blasts and T lymphocytes derived from acute leukemia patients with chemotherapy-induced cytopenia

      INTERNATIONAL IMMUNOPHARMACOLOGY
    6. Bharti, AC; Singh, SM
      Gangliosides derived from a T cell lymphoma inhibit bone marrow cell proliferation and differentiation

      INTERNATIONAL IMMUNOPHARMACOLOGY
    7. Rothenberg, EV
      Notchless T cell maturation?

      NATURE IMMUNOLOGY
    8. Druker, BJ
      Current treatment approaches for chronic myelogenous leukemia

      CANCER JOURNAL
    9. Porter, DL
      The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and nonmyeloablative allogeneic stem cell transplantation

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    10. Marijt, WAF; Falkenburg, JHF
      Specific T cell therapy in leukemia

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    11. Maki, G
      Ex vivo purging of stem cell autografts using cytotoxic cells

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    12. Godder, KT; Henslee-Downey, PJ
      Colony-stimulating factors in stem cell transplantation: Effect on qualityof life

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    13. Borbolla, JR; Najera, A; Arana, RM; Lopez-Hernandez, MA; Mendoza, Y; Trueba, E
      In vivo purging of peripheral blood stem cells obtained by apheresis, using high-dose chemotherapy and granulocyte colony-stimulating factor in chronic myelogenous leukemia patients

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    14. Hu, XT; Zuckerman, KS
      Transforming growth factor: signal transduction pathways, cell cycle mediation, and effects on hematopoiesis

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    15. Foss, B; Mentzoni, L; Bruserud, O
      Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    16. Bronte, V; Serafini, P; Apolloni, E; Zanovello, P
      Tumor-induced immune dysfunctions caused by myeloid suppressor cells

      JOURNAL OF IMMUNOTHERAPY
    17. Muller, L; Provenzani, C; Pawelec, G
      Generation of chronic myelogenous leukemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumor cell cultures

      JOURNAL OF IMMUNOTHERAPY
    18. Sconocchia, G; Cococcetta, NY; Campagnano, L; Amadori, S; Iorio, B; Boffo, V; Ferdinandi, V; Del Principe, I; Adorno, D; Casciani, CU
      Subcutaneous administration of interleukin-2 triggers Fc gamma receptor I expression on human peripheral blood neutrophils in solid and hematologic malignancies

      JOURNAL OF IMMUNOTHERAPY
    19. Morecki, S; Yacovlev, E; Gelfand, Y; Uzi, I; Slavin, S
      Cell therapy with preimmunized effector cells mismatched for minor histocompatible antigens in the treatment of a murine mammary carcinoma

      JOURNAL OF IMMUNOTHERAPY
    20. Goh, M; Chen, F; Paulsen, MT; Yeager, AM; Dyer, ES; Ljungman, M
      Phenylbutyrate attenuates the expression of Bcl-X-L, DNA-PK, caveolin-1, and VEGF in prostate cancer cells

      NEOPLASIA
    21. Tarantul, V; Nikolaev, A; Hannig, H; Kalmyrzaev, B; Muchoyan, I; Maximov, V; Nenasheva, V; Dubovaya, V; Hunsmann, G; Bodemer, W
      Detection of abundantly transcribed genes and gene translocation in human immunodeficiency virus-associated non-Hodgkin's lymphoma

      NEOPLASIA
    22. Bain, BJ
      Cytogenetics in haematology - Overview

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    23. Olney, HJ; Le Beau, MM
      The cytogenetics of myelodysplastic syndromes

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    24. Bench, AJ; Cross, NCP; Huntly, BJP; Nacheva, EP; Green, AR
      Myeloproliferative disorders

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    25. Harrison, CJ
      Acute lymphoblastic leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    26. Kearney, L
      Molecular cytogenetics

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    27. Swirsky, DM; Richards, SJ
      Laboratory diagnosis of acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    28. Mrozek, K; Heinonen, K; Bloomfield, CD
      Clinical importance of cytogenetics in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    29. Dash, A; Gilliland, DG
      Molecular genetics of acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    30. Lowenberg, B
      Prognostic factors in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    31. Langmuir, PB; Aplenc, R; Lange, BJ
      Acute myeloid leukaemia in children

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    32. Dann, EJ; Rowe, JM
      Biology and therapy of secondary leukaemias

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    33. Torelli, GF; Orsini, E; Guarini, A; Kell, J; Foa, R
      Developmental approaches in immunological control of acute myelogenous leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    34. Sonneveld, P; List, AF
      Chemotherapy resistance in acute myeloid leukaemia

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    35. Hall, PD; Virella, G; Willoughby, T; Atchley, DH; Kreitman, RJ; Frankel, AE
      Antibody response to DT-GM, a novel fusion toxin consisting of a truncateddiphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia

      CLINICAL IMMUNOLOGY
    36. Pawelec, G; Muller, L; Wagner, W
      MHC class II-restricted tumor antigens and CD4(+) T cells play a role in hematological malignancies as well as solid tumors

      TRENDS IN IMMUNOLOGY
    37. Wang, RF
      MHC class II-restricted tumor antigens and CD4(+) T cells play a role in hematological malignancies as well as solid tumors - Response

      TRENDS IN IMMUNOLOGY
    38. Matthys, P; Vermeire, K; Billiau, A
      Mac-1(+) myelopoiesis induced by CFA: a clue to the paradoxical effects ofIFN-gamma in autoimmune disease models

      TRENDS IN IMMUNOLOGY
    39. Crocker, PR; Varki, A
      Siglecs, sialic acids and innate immunity

      TRENDS IN IMMUNOLOGY
    40. Campbell, JDM; Cook, G; Holyoake, TL
      Evolution of bone marrow transplantation - the original immunotherapy

      TRENDS IN IMMUNOLOGY
    41. Barten, R; Torkar, M; Haude, A; Trowsdale, J; Wilson, MJ
      Divergent and convergent evolution of NK-cell receptors

      TRENDS IN IMMUNOLOGY
    42. Agarwala, SS; Sabbagh, MH
      Histamine dihydrochloride: inhibiting oxidants and synergising IL-2-mediated immune activation in the tumour microenvironment

      EXPERT OPINION ON BIOLOGICAL THERAPY
    43. Sievers, EL
      Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse

      EXPERT OPINION ON BIOLOGICAL THERAPY
    44. Rousseau, RF; Bollard, CM; Heslop, HE
      Gene therapy for paediatric leukaemia

      EXPERT OPINION ON BIOLOGICAL THERAPY
    45. Nawrocki, S; Wysocki, PJ; Mackiewicz, A
      Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer

      EXPERT OPINION ON BIOLOGICAL THERAPY
    46. Bhatia, V; Porter, DL
      Novel approaches to allogeneic stem cell therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    47. Joberty, G; Perlungher, RR; Sheffield, PJ; Kinoshita, M; Noda, M; Haystead, T; Macara, IG
      Borg proteins control septin organization and are negatively regulated by Cdc42

      NATURE CELL BIOLOGY
    48. Dietz, AB; Litzow, MR; Bulur, PA; Vuk-Pavlovic, S
      Transgenic interleukin 2 secreted by CML dendritic cells stimulates autologous T(H)1 T cells

      CYTOTHERAPY
    49. Mardlin, P; Chessells, JM
      Childhood leukaemia: the medical cost of cure

      HOSPITAL MEDICINE
    50. Grigg, A; Kannan, K; Schwarer, AP; Spencer, A; Szer, J
      Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantation

      INTERNAL MEDICINE JOURNAL
    51. McKelvie, PA; Wong, EY; Chow, LP; Hall, AJ
      Scedosporium endophthalmitis: two fatal disseminated cases of Scedosporiuminfection presenting with endophthalmitis

      CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
    52. Gratchev, A; Schledzewski, K; Guillot, P; Goerdt, S
      Alternatively activated antigen-presenting cells: Molecular repertoire, immune regulation, and healing

      SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY
    53. Litman, T; Druley, TE; Stein, WD; Bates, SE
      From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance

      CELLULAR AND MOLECULAR LIFE SCIENCES
    54. Marmorstein, R
      Structure and function of histone acetyltransferases

      CELLULAR AND MOLECULAR LIFE SCIENCES
    55. Graessle, S; Loidl, P; Brosch, G
      Histone acetylation: plants and fungi as model systems for the investigation of histone deacetylases

      CELLULAR AND MOLECULAR LIFE SCIENCES
    56. Timmermann, S; Lehrmann, H; Polesskaya, A; Harel-Bellan, A
      Histone acetylation and disease

      CELLULAR AND MOLECULAR LIFE SCIENCES
    57. Cant, CA; Ullrich, A
      Signal regulation by family conspiracy

      CELLULAR AND MOLECULAR LIFE SCIENCES
    58. Maru, Y; Bergmann, E; Coin, F; Egly, JM; Shibuya, M
      TFIIH functions are altered by the P210BCR-ABL oncoprotein produced on thePhiladelphia chromosome

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    59. Bolzan, AD; Paez, GL; Bianchi, MS
      FISH analysis of telomeric repeat sequences and their involvement in chromosomal aberrations induced by radiomimetic compounds in hamster cells

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    60. Giver, CR; Wong, R; Moore, DH; Pallavicini, MG
      Persistence of aneuploid immature/primitive hemopoietic sub-populations inmice 8 months after benzene exposure in vivo

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    61. Lothstein, L; Israel, M; Sweatman, TW
      Anthracycline drug targeting: cytoplasmic versus nuclear - a fork in the road

      DRUG RESISTANCE UPDATES
    62. Radojkovic, M; Ristic, S; Colovic, M; Todoric, B; Krtolica, K
      Busulfan-induced loss of Ph chromosome in chronic myeloid leukemia

      MEDICAL ONCOLOGY
    63. Krishnan, N; Buckley, DJ; Zhang, MY; Reed, JC; Buckley, AR
      Prolactin-stimulated X-linked inhibitor of apoptosis protein expression during S phase cell cycle progression in rat Nb2 lymphoma cells

      ENDOCRINE
    64. Grande, A; Montanari, M; Manfredini, R; Tagliafico, E; Zanocco-Marani, T; Trevisan, F; Ligabue, G; Siena, M; Ferrari, S; Ferrari, S
      A functionally active RAR alpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines

      CELL DEATH AND DIFFERENTIATION
    65. Angelova, M; Dolashka-Angelova, P; Ivanova, E; Serkedjieva, J; Slokoska, L; Pashova, S; Toshkova, R; Vassilev, S; Simeonov, I; Hartmann, HJ; Stoeva, S; Weser, U; Voelter, W
      A novel glycosylated Cu/Zn-containing superoxide dismutase: production andpotential therapeutic effect

      MICROBIOLOGY-SGM
    66. Farmaki, E; Roilides, E
      Immunotherapy in patients with systemic mycoses - A promising adjunct

      BIODRUGS
    67. Bruserud, O; Foss, B; Petersen, H
      Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L)

      EUROPEAN CYTOKINE NETWORK
    68. Freeburn, RW; Kendall, H; Dobson, L; Egan, J; Simler, NJ; Millar, AB
      The 3 ' untranslated region of tumor necrosis factor-alpha is highly conserved in idiopathic pulmonary fibrosis

      EUROPEAN CYTOKINE NETWORK
    69. Heisterkamp, N; Voncken, JW; Senadheera, D; Hemmeryckx, B; Gonzalez-Gomez, I; Reichert, A; Pattengale, PK; Groffen, J
      The Bcr N-terminal oligomerization domain contributes to the full oncogenicity of P190 Bcr/Abl in transgenic mice

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    70. Wang, CG; Fu, MF; Mani, S; Wadler, S; Senderowicz, AM; Pestell, RG
      Histone acetylation and the cell-cycle in cancer

      FRONTIERS IN BIOSCIENCE
    71. Filetici, P; Ornaghi, P; Ballario, P
      The bromodomain: A chromatin browser?

      FRONTIERS IN BIOSCIENCE
    72. Elgin, VE; Connolly, ES; Millar, WS; Feldstein, NA; Dwork, AJ
      Extramedullary hematopoiesis within a frontoethmoidal encephalocele in a newborn with holoprosencephaly

      PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
    73. Thomas, JG; Olson, JM; Tapscott, SJ; Zhao, LP
      An efficient and robust statistical modeling approach to discover differentially expressed genes using genomic expression profiles

      GENOME RESEARCH
    74. Gottgens, B; Gilbert, JGR; Barton, LM; Grafham, D; Rogers, J; Bentley, DR; Green, AR
      Long-range comparison of human and mouse SCL loci: Localized regions of sensitivity to restriction endonucleases correspond precisely with peaks of conserved noncoding sequences

      GENOME RESEARCH
    75. Benthin, M; Dallmann, I; Atzpodien, J
      13cis-and all-trans retinoic acid have antiproliferative effects on CML cells and render IFN alpha antiproliferative potency after combined treatmentin vitro

      CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
    76. Bagg, A
      Minimal residual disease: How low do we go?

      MOLECULAR DIAGNOSIS
    77. Khoury, H; Adkins, D; Brown, R; Pence, H; Vij, R; Goodnough, LT; Westervelt, P; Trinkaus, K; Lin, HS; DiPersio, J
      Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    78. Patterson, AE; Korngold, R
      Infusion of select leukemia-reactive TCR V beta(+) T cells provides graft-versus leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    79. Alvarnas, JC; Linn, YC; Hope, EG; Negrin, RS
      Expansion of cytotoxic CD3(+)CD56(+) cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    80. Porter, DL; Luger, SM; Duffy, KM; Stadtmauer, EA; Laport, G; Schuster, SJ; Orloff, G; Tsai, D; McDaid, K; Kathakali, A; Leonard, DGB; Antin, JH
      Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    81. Johnson, BD; Dagher, N; Stankowski, MC; Hanke, CA; Truitt, RL
      Donor natural killer (NK1.1(+)) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    82. Dey, BR; McAfee, S; Sackstein, R; Colby, C; Saidman, S; Weymouth, D; Poliquin, C; Vanderklish, J; Sachs, DH; Sykes, M; Spitzer, TR
      Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    83. Shimoni, A; Gajewski, J; Donato, M; Martin, T; O'Brien, S; Talpaz, M; Cohen, A; Korbling, M; Champlin, R; Giralt, S
      Long-term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    84. Kummar, S; Ishii, A; Yang, HK; Venzon, DJ; Kim, SJ; Gress, RE
      Modulation of graft-versus-tumor effects in a murine allogeneic bone marrow transplantation model by tumor-derived transforming growth factor-beta 1

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    85. Carlens, S; Remberger, M; Aschan, J; Ringden, O
      The role of disease stage in the response to donor lymphocyte infusions astreatment for leukemic relapse

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    86. Bartolo, C; Viswanatha, DS
      Molecular methods for minimal residual disease detection in hematolymphoiddiseases: Principles and applications

      JOURNAL OF CLINICAL LIGAND ASSAY
    87. Weissman, IL; Anderson, DJ; Gage, F
      Stem and progenitor cells: Origins, phenotypes, lineage commitments, and transdifferentiations

      ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY
    88. Bartley, PA; Lutwyche, JK; Gonda, TJ
      Identification and validation of candidate Myb target genes

      BLOOD CELLS MOLECULES AND DISEASES
    89. Bartley, PA; Lutwyche, JK; Gonda, TJ
      Identification and validation of candidate Myb target genes

      BLOOD CELLS MOLECULES AND DISEASES
    90. Richon, VM; Zhou, XB; Rifkind, RA; Marks, PA
      Histone deacetylase inhibitors: Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers

      BLOOD CELLS MOLECULES AND DISEASES
    91. Honda, H; Hirai, H
      Model mice for BCR/ABL-positive leukemias

      BLOOD CELLS MOLECULES AND DISEASES
    92. Dazzi, F; Simpson, E; Goldman, JM
      Minor antigen solves major problem

      NATURE MEDICINE
    93. Hiebert, S
      Differentiation or leukemia: Is C/EBP alpha the answer?

      NATURE MEDICINE
    94. Vigneri, P; Wang, JYJ
      Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase

      NATURE MEDICINE
    95. Sachithanandan, A; Cuthbert, RJG; d'Sa, AABB
      Interferon induced severe digital ischaemia in chronic myeloid leukaemia -Successful treatment using ketanserin

      EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
    96. Dent, P; Grant, S
      Pharmacologic interruption of the mitogen-activated extracellular-regulated kinase/mitogen-activated protein kinase signal transduction pathway: Potential role in promoting cytotoxic drug action

      CLINICAL CANCER RESEARCH
    97. Ferrajoli, A; Manshouri, T; Estrov, Z; Keating, MJ; O'Brien, S; Lerner, S; Beran, M; Kantarjian, HM; Freireich, EJ; Albitar, M
      High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia

      CLINICAL CANCER RESEARCH
    98. Narla, RK; Dong, YH; Klis, D; Uckun, FM
      Bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) as a novel antileukemic agent with matrix metalloproteinase inhibitory activity

      CLINICAL CANCER RESEARCH
    99. Gaiger, A; Carter, L; Greinix, H; Carter, D; McNeill, PD; Houghton, RL; Cornellison, CD; Vedvick, TS; Skeiky, YAW; Cheever, MA
      WT1-specific serum antibodies in patients with leukemia

      CLINICAL CANCER RESEARCH
    100. Gilliland, DG
      The diverse role of the ETS family of transcription factors in cancer - Commentary re: B. Davidson, Ets-1 messenger RNA expression is a novel marker of poor survival in ovarian carcinoma. Clin. Cancer Res., 7 : 551-557, 2001.

      CLINICAL CANCER RESEARCH


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 19:17:46